Application Regioselective deprotonation at C-3 with LDA followed by trapping with carbon dioxide provides the correspondin nicotinic acid.1 Packaging 1 g in glass bottle 500 mg in glass bottle
2-Bromo-4-(trifluoromethyl)pyridine in used in the preparation of pyrazolopyridines as kinase LRRK2 inhibitors for treating and preventing cancer and neurodegenerative diseases.
References
PubChem Literature
From Data Sources
• Tyvorskii., et al.: Tetrahedron, 57, 2051 (2001)
Bioactivity
PubChem BioAssay
Properties
Safety Information
Storage Warning
IRRITANT
Harmful/Irritant/Light Sensitive/Store under Argon/Keep Cold